Christopher Posner Cara Therapeutics, Inc. (CARA) insider trading activity

Christopher Posner is PRESIDENT AND CEO of Cara Therapeutics, Inc.. Currently has a direct ownership of 13,109 shares of CARA, which is worth approximately $67,249. The most recent transaction as insider was on Feb 28, 2025, when has been sold 583 shares (Common Stock) at a price of $4.75 per share, resulting in proceeds of $2,769. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 13.1K

92.23% 3M change

92.74% 12M change

Total Value Held $67,249

Christopher Posner Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 28 2025	SELL Open market or private sale	$2,769 $4.75 p/Share	583 Reduced 4.26%	13,109 Common Stock
Feb 04 2025	SELL Open market or private sale	$1,755 $4.72 p/Share	372 Reduced 2.65%	13,692 Common Stock
Nov 04 2024	SELL Open market or private sale	$1,063 $0.29 p/Share	3,668 Reduced 2.13%	168,768 Common Stock
Aug 01 2024	SELL Open market or private sale	$1,452 $0.35 p/Share	4,149 Reduced 2.35%	172,436 Common Stock
May 02 2024	SELL Open market or private sale	$2,952 $0.75 p/Share	3,936 Reduced 2.18%	176,585 Common Stock
Feb 29 2024	SELL Open market or private sale	$5,192 $0.89 p/Share	5,834 Reduced 3.13%	180,521 Common Stock
Feb 08 2024	SELL Open market or private sale	$18,854 $0.53 p/Share	35,575 Reduced 16.03%	186,355 Common Stock
Feb 01 2024	SELL Open market or private sale	$2,739 $0.55 p/Share	4,981 Reduced 2.2%	221,930 Common Stock
Feb 01 2024	BUY Grant, award, or other acquisition	-	62,500 Added 21.6%	226,911 Common Stock
Nov 02 2023	SELL Open market or private sale	$4,631 $1.22 p/Share	3,796 Reduced 2.26%	164,411 Common Stock
Aug 03 2023	SELL Open market or private sale	$13,222 $3.07 p/Share	4,307 Reduced 2.5%	168,207 Common Stock
May 05 2023	SELL Open market or private sale	$17,023 $4.4 p/Share	3,869 Reduced 2.19%	172,514 Common Stock
Mar 03 2023	SELL Open market or private sale	$58,133 $9.71 p/Share	5,987 Reduced 3.28%	176,383 Common Stock
Feb 02 2023	SELL Open market or private sale	$49,453 $11.8 p/Share	4,191 Reduced 2.25%	182,370 Common Stock
Nov 16 2022	SELL Open market or private sale	$161,051 $11.13 p/Share	14,470 Reduced 7.2%	186,561 Common Stock
Apr 04 2022	SELL Open market or private sale	$25,416 $12.67 p/Share	2,006 Reduced 0.99%	201,031 Common Stock
Feb 25 2022	BUY Grant, award, or other acquisition	-	39,000 Added 16.11%	203,037 Common Stock
Oct 29 2021	BUY Grant, award, or other acquisition	-	147,941 Added 47.42%	164,037 Common Stock
Jun 07 2021	SELL Open market or private sale	$30,044 $13.04 p/Share	2,304 Reduced 12.52%	16,096 Common Stock
Jun 03 2021	BUY Grant, award, or other acquisition	-	7,200 Added 28.13%	18,400 Common Stock
Nov 19 2020	SELL Open market or private sale	$31,640 $15.82 p/Share	2,000 Reduced 15.15%	11,200 Common Stock

Christopher Posner

PRESIDENT AND CEO

Stamford, CT

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CARA shares.

Notify only if

Value

Insider Trading

Get notified when an Cara Therapeutics, Inc. insider buys or sells CARA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Cara Therapeutics, Inc.

Track Activities on CARA

Account